LIFECORE BIOMEDICAL, INC. Selling, General and Administrative Expense
LIFECORE BIOMEDICAL, INC. (LFCR) reported Selling, General and Administrative Expense of $7.97 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-05
- LIFECORE BIOMEDICAL, INC. selling, general and administrative expense for the quarter ending 2026-06-30 was $7.97M.
- LIFECORE BIOMEDICAL, INC. selling, general and administrative expense for the quarter ending 2026-03-31 was $7.92M.
- LIFECORE BIOMEDICAL, INC. selling, general and administrative expense for the quarter ending 2025-09-30 was $8.89M.
- LIFECORE BIOMEDICAL, INC. selling, general and administrative expense for the quarter ending 2025-05-25 was $8.98M, a 26.55% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. selling, general and administrative expense for fiscal 2025 was $44.05M, a 8.86% increase from fiscal 2024.
- LIFECORE BIOMEDICAL, INC. selling, general and administrative expense for fiscal 2024 was $40.46M, a 3.83% increase from fiscal 2023.
- LIFECORE BIOMEDICAL, INC. selling, general and administrative expense for fiscal 2023 was $38.97M, a 12.44% increase from fiscal 2022.
- LIFECORE BIOMEDICAL, INC. selling, general and administrative expense for fiscal 2022 was $34.66M, a 25.03% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 1 month | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 7 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $7.97M 10-Q · filed 2026-08-05 | $15.89M 10-Q · filed 2026-08-05 | ||||||||
| 2026-03-31 | $7.92M 10-Q · filed 2026-05-06 | |||||||||
| 2025-12-31 | $19.46M 10-KT · filed 2026-03-16 | |||||||||
| 2025-09-30 | $8.89M 10-Q · filed 2025-11-06 | |||||||||
| 2025-06-30 | $3.02M 10-KT · filed 2026-03-16 | |||||||||
| 2025-05-25 | $8.98M 10-Q · filed 2026-08-05 | $19.07M 10-Q · filed 2026-08-05 | $30.08M derived: sum of 3 quarters · filed 2026-08-05 | $44.05M 10-KT · filed 2026-03-16 | ||||||
| 2025-02-23 | $9.98M 10-Q · filed 2026-05-06 | $10.09M 10-Q · filed 2025-04-03 | $21.10M derived: sum of 2 quarters · filed 2026-05-06 | $35.07M 10-Q · filed 2025-04-03 | $48.11M derived: sum of 4 quarters · filed 2026-05-06 | |||||
| 2024-12-31 | $30.85M 10-KT · filed 2026-03-16 | |||||||||
| 2024-11-24 | $11.12M 10-Q · filed 2025-01-02 | $25.90M 10-Q · filed 2025-01-02 | $38.13M derived: sum of 3 quarters · filed 2026-03-16 | $47.98M derived: sum of 4 quarters · filed 2026-03-16 | ||||||
| 2024-08-25 | $14.79M 10-Q · filed 2025-11-06 | $27.01M derived: sum of 2 quarters · filed 2026-03-16 | $36.86M derived: sum of 3 quarters · filed 2026-03-16 | $46.20M derived: sum of 4 quarters · filed 2026-03-16 | ||||||
| 2024-05-26 | $12.23M derived: 10-KT 12 month − 10-Q 9 month · filed 2026-03-16 | $22.07M derived: sum of 2 quarters · filed 2026-03-16 | $31.42M derived: sum of 3 quarters · filed 2026-03-16 | $40.46M 10-KT · filed 2026-03-16 | ||||||
| 2024-02-25 | $9.85M 10-Q · filed 2025-04-03 | $19.19M derived: sum of 2 quarters · filed 2025-04-03 | $28.24M 10-Q · filed 2025-04-03 | $28.24M 10-Q · filed 2024-08-09 | $40.68M derived: sum of 4 quarters · filed 2025-04-03 | |||||
| 2023-11-26 | $9.34M 10-Q · filed 2025-01-02 | $9.19M 10-Q · filed 2024-08-09 | $18.54M 10-Q · filed 2025-01-02 | $18.39M 10-Q · filed 2024-08-09 | $30.83M derived: sum of 3 quarters · filed 2025-01-02 | $41.11M derived: sum of 4 quarters · filed 2025-01-02 | ||||
| 2023-08-27 | $9.20M 10-Q · filed 2024-10-04 | $9.21M 10-Q · filed 2024-08-09 | $21.49M derived: sum of 2 quarters · filed 2024-10-04 | $31.77M derived: sum of 3 quarters · filed 2024-10-04 | $40.06M derived: sum of 4 quarters · filed 2024-10-04 | |||||
| 2023-05-28 | $12.29M derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-26 | $22.57M derived: sum of 2 quarters · filed 2024-08-26 | $30.86M derived: sum of 3 quarters · filed 2024-08-26 | $38.97M 10-K · filed 2024-08-26 | ||||||
| 2023-02-26 | $10.28M 10-Q · filed 2024-08-09 | $10.97M 10-Q · filed 2023-06-02 | $18.57M derived: sum of 2 quarters · filed 2024-08-09 | $26.68M 10-Q · filed 2024-08-09 | $31.20M 10-Q · filed 2023-06-02 | $33.67M derived: sum of 4 quarters · filed 2024-08-26 | ||||
| 2022-11-27 | $8.29M 10-Q · filed 2024-08-09 | $10.77M 10-Q · filed 2023-03-16 | $16.39M 10-Q · filed 2024-08-09 | $21.43M 10-Q · filed 2023-03-16 | $23.39M derived: sum of 3 quarters · filed 2024-08-26 | $37.14M derived: sum of 4 quarters · filed 2024-08-26 | ||||
| 2022-08-28 | $8.10M 10-Q · filed 2024-08-09 | $10.88M 10-Q · filed 2022-10-07 | $15.10M derived: sum of 2 quarters · filed 2024-08-26 | $28.85M derived: sum of 3 quarters · filed 2024-08-26 | $34.31M derived: sum of 4 quarters · filed 2024-08-26 | |||||
| 2022-05-29 | $7.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-26 | $20.75M derived: sum of 2 quarters · filed 2024-08-26 | $26.21M derived: sum of 3 quarters · filed 2024-08-26 | $34.66M 10-K · filed 2024-08-26 | $46.13M 10-K · filed 2022-09-14 | |||||
| 2022-02-27 | $13.75M 10-K · filed 2024-03-20 | $9.72M 10-Q · filed 2022-04-07 | $19.21M derived: sum of 2 quarters · filed 2024-03-20 | $27.66M 10-Q · filed 2023-06-02 | $27.21M 10-Q · filed 2022-04-07 | $25.91M derived: sum of 4 quarters · filed 2024-03-20 | ||||
| 2021-11-28 | $5.46M 10-K · filed 2024-03-20 | $13.84M 10-Q · filed 2022-01-07 | $17.48M 10-Q · filed 2023-03-16 | $29.77M 10-Q · filed 2022-01-07 | $12.16M derived: sum of 3 quarters · filed 2024-03-20 | $19.31M derived: sum of 4 quarters · filed 2024-03-20 | ||||
| 2021-08-29 | $6.95M 10-K · filed 2024-03-20 | $15.94M 10-Q · filed 2021-10-05 | $6.70M derived: sum of 2 quarters · filed 2024-03-20 | $13.85M derived: sum of 3 quarters · filed 2024-03-20 | $20.56M derived: sum of 4 quarters · filed 2024-03-20 | |||||
| 2021-05-30 | -$247.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $6.90M derived: sum of 2 quarters · filed 2024-03-20 | $13.61M derived: sum of 3 quarters · filed 2024-03-20 | $27.72M 10-K · filed 2024-03-20 | $65.36M 10-K · filed 2021-07-29 | |||||
| 2021-02-28 | $7.15M 10-K · filed 2024-03-20 | $15.22M 10-Q · filed 2021-04-08 | $13.86M derived: sum of 2 quarters · filed 2024-03-20 | $27.97M 10-Q · filed 2022-04-07 | $49.23M 10-Q · filed 2021-04-08 | $8.02M derived: sum of 4 quarters · filed 2024-03-20 | ||||
| 2020-11-29 | $6.71M 10-K · filed 2024-03-20 | $16.11M 10-Q · filed 2021-01-07 | $34.01M 10-Q · filed 2022-01-07 | $874.00K derived: sum of 3 quarters · filed 2024-03-20 | $19.66M derived: sum of 4 quarters · filed 2024-03-20 | |||||
| 2020-08-30 | $7.49M 10-K · filed 2024-03-20 | $17.90M 10-Q · filed 2020-10-07 | -$5.84M derived: sum of 2 quarters · filed 2024-03-20 | $12.95M derived: sum of 3 quarters · filed 2024-03-20 | $31.68M derived: sum of 4 quarters · filed 2024-03-20 | |||||
| 2020-05-31 | -$13.33M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-16 | $5.46M derived: sum of 2 quarters · filed 2023-03-16 | $24.18M derived: sum of 3 quarters · filed 2023-03-16 | $40.67M 10-K/A · filed 2023-03-16 | $72.19M 10-K · filed 2020-08-14 | |||||
| 2020-02-23 | $18.78M 10-Q · filed 2021-04-08 | $37.51M derived: sum of 2 quarters · filed 2021-04-08 | $54.00M 10-Q · filed 2021-04-08 | $72.68M derived: sum of 4 quarters · filed 2021-07-29 | ||||||
| 2019-11-24 | $18.73M 10-Q · filed 2021-01-07 | $35.62M 10-Q · filed 2021-01-07 | $53.89M derived: sum of 3 quarters · filed 2021-07-29 | $69.48M derived: sum of 4 quarters · filed 2021-07-29 | ||||||
| 2019-08-25 | $16.89M 10-Q · filed 2020-10-07 | $35.17M derived: sum of 2 quarters · filed 2021-07-29 | $50.75M derived: sum of 3 quarters · filed 2021-07-29 | $65.15M derived: sum of 4 quarters · filed 2021-07-29 | ||||||
| 2019-05-26 | $18.27M derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-29 | $33.86M derived: sum of 2 quarters · filed 2021-07-29 | $48.26M derived: sum of 3 quarters · filed 2021-07-29 | $62.06M 10-K · filed 2021-07-29 | $64.06M 10-K · filed 2019-08-01 | |||||
| 2019-02-24 | $15.59M 10-Q · filed 2020-04-03 | $15.84M 10-Q · filed 2019-04-04 | $29.99M derived: sum of 2 quarters · filed 2020-04-03 | $43.79M 10-Q · filed 2020-04-03 | $44.46M 10-Q · filed 2019-04-04 | $56.93M derived: sum of 4 quarters · filed 2020-08-14 | ||||
| 2018-11-25 | $14.40M 10-Q · filed 2020-01-02 | $14.67M 10-Q · filed 2019-01-07 | $28.20M 10-Q · filed 2020-01-02 | $28.62M 10-Q · filed 2019-01-07 | $41.34M derived: sum of 3 quarters · filed 2020-08-14 | $54.55M derived: sum of 4 quarters · filed 2020-08-14 | ||||
| 2018-08-26 | $13.80M 10-Q · filed 2019-10-03 | $13.95M 10-Q · filed 2018-10-05 | $26.94M derived: sum of 2 quarters · filed 2020-08-14 | $40.15M derived: sum of 3 quarters · filed 2020-08-14 | $52.40M derived: sum of 4 quarters · filed 2020-08-14 | |||||
| 2018-05-27 | $13.14M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-14 | $26.35M derived: sum of 2 quarters · filed 2020-08-14 | $38.59M derived: sum of 3 quarters · filed 2020-08-14 | $51.95M 10-K · filed 2020-08-14 | ||||||
| 2018-02-25 | $13.21M 10-Q · filed 2019-04-04 | $13.81M 10-Q · filed 2018-04-05 | $25.45M derived: sum of 2 quarters · filed 2019-04-04 | $38.81M 10-Q · filed 2019-04-04 | $40.79M 10-Q · filed 2018-04-05 | $49.33M derived: sum of 4 quarters · filed 2019-08-01 | ||||
| 2017-11-26 | $12.24M 10-Q · filed 2019-01-07 | $12.93M 10-Q · filed 2018-01-05 | $25.60M 10-Q · filed 2019-01-07 | $26.98M 10-Q · filed 2018-01-05 | $36.12M derived: sum of 3 quarters · filed 2019-08-01 | $51.13M derived: sum of 4 quarters · filed 2019-08-01 | ||||
| 2017-08-27 | $13.36M 10-Q · filed 2018-10-05 | $14.04M 10-Q · filed 2017-09-28 | $23.88M derived: sum of 2 quarters · filed 2019-08-01 | $38.89M derived: sum of 3 quarters · filed 2019-08-01 | $52.61M derived: sum of 4 quarters · filed 2019-08-01 | |||||
| 2017-05-28 | $10.52M derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-01 | $25.53M derived: sum of 2 quarters · filed 2019-08-01 | $39.26M derived: sum of 3 quarters · filed 2019-08-01 | $52.49M 10-K · filed 2019-08-01 | $55.63M 10-K · filed 2017-08-11 | |||||
| 2017-02-26 | $15.01M 10-Q · filed 2018-04-05 | $28.73M derived: sum of 2 quarters · filed 2018-04-05 | $41.97M 10-Q · filed 2018-04-05 | $53.01M derived: sum of 4 quarters · filed 2018-08-09 | ||||||
| 2016-11-27 | $13.72M 10-Q · filed 2018-01-05 | $27.46M 10-Q · filed 2018-01-05 | $38.00M derived: sum of 3 quarters · filed 2018-08-09 | $48.66M derived: sum of 4 quarters · filed 2018-08-09 | ||||||
| 2016-08-28 | $13.74M 10-Q · filed 2017-09-28 | $24.28M derived: sum of 2 quarters · filed 2018-08-09 | $34.94M derived: sum of 3 quarters · filed 2018-08-09 | $47.75M derived: sum of 4 quarters · filed 2018-08-09 | ||||||
| 2016-05-29 | $10.54M derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-09 | $21.20M derived: sum of 2 quarters · filed 2018-08-09 | $34.02M derived: sum of 3 quarters · filed 2018-08-09 | $46.18M 10-K · filed 2018-08-09 | $49.52M 10-K · filed 2016-08-01 | |||||
| 2016-02-28 | $10.66M 10-Q · filed 2017-04-07 | $23.47M derived: sum of 2 quarters · filed 2017-04-07 | $35.64M 10-Q · filed 2017-04-07 | $46.49M derived: sum of 4 quarters · filed 2018-03-15 | ||||||
| 2015-11-29 | $12.81M 10-Q · filed 2017-01-05 | $24.98M 10-Q · filed 2017-01-05 | $35.83M derived: sum of 3 quarters · filed 2018-03-15 | $46.13M derived: sum of 4 quarters · filed 2018-03-15 | ||||||
| 2015-08-30 | $12.16M 10-Q · filed 2016-09-29 | $23.02M derived: sum of 2 quarters · filed 2018-03-15 | $33.31M derived: sum of 3 quarters · filed 2018-03-15 | $43.26M derived: sum of 4 quarters · filed 2018-03-15 | ||||||
| 2015-05-31 | $10.85M derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-03-15 | $21.15M derived: sum of 2 quarters · filed 2018-03-15 | $31.10M derived: sum of 3 quarters · filed 2018-03-15 | $39.96M 10-K/A · filed 2018-03-15 | ||||||
| 2015-03-01 | $10.30M 10-Q · filed 2016-03-30 | $20.25M derived: sum of 2 quarters · filed 2016-03-30 | $29.11M 10-Q · filed 2016-03-30 | $38.31M derived: sum of 4 quarters · filed 2016-08-01 | ||||||
| 2014-11-30 | $9.95M 10-Q · filed 2016-01-07 | $18.81M 10-Q · filed 2016-01-07 | $28.01M derived: sum of 3 quarters · filed 2016-08-01 | $36.71M derived: sum of 4 quarters · filed 2016-08-01 | ||||||
| 2014-08-31 | $8.86M 10-Q · filed 2015-10-01 | $18.06M derived: sum of 2 quarters · filed 2016-08-01 | $26.76M derived: sum of 3 quarters · filed 2016-08-01 | $35.40M derived: sum of 4 quarters · filed 2016-08-01 | ||||||
| 2014-05-25 | $9.20M derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-01 | $17.90M derived: sum of 2 quarters · filed 2016-08-01 | $26.54M derived: sum of 3 quarters · filed 2016-08-01 | $35.17M 10-K · filed 2016-08-01 | ||||||
| 2014-02-23 | $8.70M 10-Q · filed 2015-04-02 | $17.34M derived: sum of 2 quarters · filed 2015-04-02 | $25.97M 10-Q · filed 2015-04-02 | $32.23M derived: sum of 4 quarters · filed 2015-07-31 | ||||||
| 2013-11-24 | $8.64M 10-Q · filed 2015-01-09 | $17.27M 10-Q · filed 2015-01-09 | $23.53M derived: sum of 3 quarters · filed 2015-07-31 | $32.06M derived: sum of 4 quarters · filed 2015-07-31 | ||||||
| 2013-08-25 | $8.63M 10-Q · filed 2014-10-08 | $14.89M derived: sum of 2 quarters · filed 2015-07-31 | $23.42M derived: sum of 3 quarters · filed 2015-07-31 | $32.60M derived: sum of 4 quarters · filed 2015-07-31 | ||||||
| 2013-05-26 | $6.26M derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-31 | $14.79M derived: sum of 2 quarters · filed 2015-07-31 | $23.98M derived: sum of 3 quarters · filed 2015-07-31 | $32.53M 10-K · filed 2015-07-31 | ||||||
| 2013-02-24 | $8.52M 10-Q · filed 2014-03-28 | $17.71M derived: sum of 2 quarters · filed 2014-03-28 | $26.27M 10-Q · filed 2014-03-28 | $33.61M derived: sum of 4 quarters · filed 2014-08-01 | ||||||
| 2012-11-25 | $9.19M 10-Q · filed 2014-01-03 | $17.74M 10-Q · filed 2014-01-03 | $25.09M derived: sum of 3 quarters · filed 2014-08-01 | $31.75M derived: sum of 4 quarters · filed 2014-08-01 | ||||||
| 2012-08-26 | $8.56M 10-Q · filed 2013-09-26 | $15.90M derived: sum of 2 quarters · filed 2014-08-01 | $22.56M derived: sum of 3 quarters · filed 2014-08-01 | $29.03M derived: sum of 4 quarters · filed 2014-08-01 | ||||||
| 2012-05-27 | $7.34M derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-01 | $14.01M derived: sum of 2 quarters · filed 2014-08-01 | $20.47M derived: sum of 3 quarters · filed 2014-08-01 | $26.52M 10-K · filed 2014-08-01 | ||||||
| 2012-02-26 | $6.66M 10-Q · filed 2013-04-04 | $13.13M derived: sum of 2 quarters · filed 2013-04-04 | $19.17M 10-Q · filed 2013-04-04 | $25.60M derived: sum of 4 quarters · filed 2013-08-07 | ||||||
| 2011-11-27 | $6.46M 10-Q · filed 2013-01-04 | $12.51M 10-Q · filed 2013-01-04 | $18.93M derived: sum of 3 quarters · filed 2013-08-07 | $25.39M derived: sum of 4 quarters · filed 2013-08-07 | ||||||
| 2011-08-28 | $6.04M 10-Q/A · filed 2013-01-02 | $12.47M derived: sum of 2 quarters · filed 2013-08-07 | $18.93M derived: sum of 3 quarters · filed 2013-08-07 | $25.00M derived: sum of 4 quarters · filed 2013-08-07 | ||||||
| 2011-05-29 | $6.42M derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-07 | $12.88M derived: sum of 2 quarters · filed 2013-08-07 | $18.95M derived: sum of 3 quarters · filed 2013-08-07 | $24.61M 10-K · filed 2013-08-07 | ||||||
| 2011-02-27 | $6.46M 10-Q · filed 2012-03-28 | $12.53M derived: sum of 2 quarters · filed 2012-03-28 | $18.18M 10-Q · filed 2012-03-28 | |||||||
| 2010-11-28 | $6.07M 10-Q · filed 2012-01-05 | $11.72M 10-Q · filed 2012-01-05 | ||||||||
| 2010-08-29 | $5.65M 10-Q · filed 2011-10-05 | |||||||||
| 2010-05-30 | $17.70M 10-K · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |